Corcept Therapeutics Incorporated · NASDAQ:CORT
Belanoff Joseph K sold 12,837 Corcept Therapeutics Incorporated shares (Form 4)
Traded May 29 to Jun 1, 2026 · Filed Jun 2, 2026
From May 29 to Jun 1, 2026, Belanoff Joseph K (Director, Chief Executive Officer) sold 12,837 Corcept Therapeutics Incorporated shares at US$69.74 for US$895K under a trading plan, leaving 2,565,489 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 12,837 shares
- Price
- US$69.74
- Value
- US$895K
- Holding after
- 2,565,489 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Gift | 300,000 | 2,578,326 | Indirect | |
| May 29, 2026 | Common Stock | Gift | 150,000 | 150,000 | Indirect | |
| Jun 1, 2026 | Common Stock | Sale | 12,837 | US$69.74 | 2,565,489 | Indirect |
Source
Related
- Corcept Therapeutics Incorporated
- Belanoff Joseph K
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Belanoff Joseph K · May 5, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026